These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2096 related items for PubMed ID: 7628364

  • 1. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S, Smith MA, Gold PW.
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [Abstract] [Full Text] [Related]

  • 2. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP, Wiegand SJ, Watson SJ.
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [Abstract] [Full Text] [Related]

  • 3. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress.
    Makino S, Schulkin J, Smith MA, Pacák K, Palkovits M, Gold PW.
    Endocrinology; 1995 Oct; 136(10):4517-25. PubMed ID: 7664672
    [Abstract] [Full Text] [Related]

  • 4. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA.
    Ma XM, Levy A, Lightman SL.
    Endocrinology; 1997 Oct; 138(10):4351-7. PubMed ID: 9322950
    [Abstract] [Full Text] [Related]

  • 5. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
    Schwartz MW, Strack AM, Dallman MF.
    Regul Pept; 1997 Oct 31; 72(2-3):105-12. PubMed ID: 9652969
    [Abstract] [Full Text] [Related]

  • 6. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
    Makino S, Tanaka Y, Nazarloo HP, Noguchi T, Nishimura K, Hashimoto K.
    Brain Res; 2005 Jun 28; 1048(1-2):131-7. PubMed ID: 15919058
    [Abstract] [Full Text] [Related]

  • 7. Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release.
    Viau V, Chu A, Soriano L, Dallman MF.
    J Neurosci; 1999 Aug 01; 19(15):6684-93. PubMed ID: 10414997
    [Abstract] [Full Text] [Related]

  • 8. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress.
    Makino S, Smith MA, Gold PW.
    Brain Res; 2002 Jul 12; 943(2):216-23. PubMed ID: 12101044
    [Abstract] [Full Text] [Related]

  • 9. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
    Walker CD, Tankosic P, Tilders FJ, Burlet A.
    J Neuroendocrinol; 1997 Jan 12; 9(1):25-41. PubMed ID: 9023736
    [Abstract] [Full Text] [Related]

  • 10. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone.
    Glavas MM, Ellis L, Yu WK, Weinberg J.
    Alcohol Clin Exp Res; 2007 Sep 12; 31(9):1598-610. PubMed ID: 17760789
    [Abstract] [Full Text] [Related]

  • 11. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V, Soriano L, Dallman MF.
    J Neuroendocrinol; 2001 May 12; 13(5):442-52. PubMed ID: 11328455
    [Abstract] [Full Text] [Related]

  • 12. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus.
    Albeck DS, Hastings NB, McEwen BS.
    Brain Res Mol Brain Res; 1994 Oct 12; 26(1-2):129-34. PubMed ID: 7854039
    [Abstract] [Full Text] [Related]

  • 13. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN, Reid RL, Van Vugt DA.
    Endocrinology; 1999 May 12; 140(5):2191-8. PubMed ID: 10218971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of fetal adrenalectomy at 110 days gestational age on AVP and CRH mRNA expression in the hypothalamic paraventricular nucleus of the ovine fetus.
    Unno N, Wu WX, Ding XY, Li C, Hing WK, Nathanielsz PW.
    Brain Res Dev Brain Res; 1998 Mar 12; 106(1-2):119-28. PubMed ID: 9554977
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The magnocellular arginine-vasopressin mRNA responds differently to food deprivation between the supraoptic and paraventricular nuclei of the hypothalamus in adrenalectomized rats with low corticosterone replacement.
    Ogasa T, Hashimoto K, Suemaru S, Kageyama J, Ota Z.
    Brain Res; 1992 Jun 26; 583(1-2):45-53. PubMed ID: 1504843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 105.